DrugId:  1
1. Name:  Porphyrin Fe(III)
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  2
1. Name:  Temoporfin
2. Groups:  Approved, Investigational
3. Description:  Temoporfin is a photosensitizing agent used in the treatment of squamous cell carcinoma of the head and neck [FDA Label]. It was first authorized for market by the European Medicines Agency in October 2001. It is currently available under the brand name Foscan.
4. Indication:  For use in the treatment of patients with advanced squamous cell carcinoma of the head and neck failing standard therapies and who are unsuitable for radiotherapy, surgery, or systemic chemotherapy [FDA Label].
